Preclinical testing of the ketogenic diet in fragile X mice
- 1 March 2020
- journal article
- research article
- Published by Elsevier in Neurochemistry International
- Vol. 134, 104687
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- FRAXA Research Foundation
This publication has 102 references indexed in Scilit:
- The translational regulator FMRP controls lipid and glucose metabolism in mice and humansMolecular Metabolism, 2019
- Deficient Sleep in Mouse Models of Fragile X SyndromeFrontiers in Molecular Neuroscience, 2017
- Tissue Specific Impacts of a Ketogenic Diet on Mitochondrial Dynamics in the BTBRT+tf/j MouseFrontiers in Physiology, 2016
- Autism spectrum disorder and epilepsy: the role of ketogenic diet2016
- Targeting Translation Control with p70 S6 Kinase 1 Inhibitors to Reverse Phenotypes in Fragile X Syndrome MiceNeuropsychopharmacology, 2015
- Ketogenic Diet Improves Core Symptoms of Autism in BTBR MicePLOS ONE, 2013
- Inhibition of Spontaneous Recovery of Fear by mGluR5 after Prolonged Extinction TrainingPLOS ONE, 2013
- Effect of a High-Fat Ketogenic Diet on Plasma Levels of Lipids, Lipoproteins, and Apolipoproteins in ChildrenJAMA, 2003
- Fmr1 knockout mouse has a distinctive strain-specific learning impairmentNeuroscience, 2000
- Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndromeCell, 1991